Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Characterisation of humoral and cellular immunity of low- and high-responders after TBE vaccination
2008-005800-24Phase 4Completed
- Sponsor
- Institute of Specific Prophylaxis and Tropical Medicine
- Start
- Sep 2008
- Modality
- Whole Inactivated Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4, single-arm trial of FSME-IMMUN in tick-borne encephalitis (TBE), sponsored by Institute of Specific Prophylaxis and Tropical Medicine. Primary endpoint: Cellular TBE immunity (cytokine production) 7 days after TBE-booster vaccination plus influenza vaccination. Started Sep 2008; status: completed.
02
Drugs
FSME-IMMUN
03
Conditions
tick-borne encephalitis (TBE)
Beyond the preview
Go deeper on 2008-005800-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-005800-24.